SCLEROSTIN EPITOPE

Patent europeic · EP2345668 · Stritgà

Inscripziun en il register

Numer da publicaziun: EP2345668
Numer da la dumonda: EP10014360
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: Stritgà
Scrittira da patent: Concedì
Annunzià: 28-04-2006
Publitgà: 20-07-2011
Concedì: 22-09-2021
Stritgà: 28-04-2026
Motiv: Durada maximala cuntanschida
Classas IPC: C07K 16/22 (2006.01)
A61K 39/00 (2006.01)
C12N 15/63 (2006.01)
A61P 15/12 (2006.01)
C07K 14/51 (2006.01)
A61P 19/00 (2006.01)
A61P 19/08 (2006.01)
A61P 19/10 (2006.01)
A61P 43/00 (2006.01)
Prioritad: US 677583 P 03.05.2005
US 776847 P 24.02.2006
US 782244 P 13.03.2006
US 792645 P 17.04.2006
US 410540 25.04.2006
Lingua da l’annunzia: englais
Funtauna: Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

28-04-2026
Durada maximala cuntanschida
Status of protective title
Active → Cancelled
Cancellation date
28.04.2026
Cause for cancellation
Expiry of maximum term of protection
Published in Swissreg on 28.04.2026
01-05-2025
Midada
Published in Swissreg on 01.05.2025
15-01-2025
Represchentant stritgà
Representative
OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern (allontanà)
Published in Swissreg on 15.01.2025
15-01-2025
Represchentant inscrit
Representative
OFFICE ERNEST FREYLINGER S.A., c/o Schluep IP Law AG, Falkenplatz 7, 3012 Bern
Published in Swissreg on 15.01.2025
01-05-2024
Midada
Published in Swissreg on 01.05.2024
07-06-2023
Midada
Published in Swissreg on 07.06.2023
01-05-2023
Midada
Published in Swissreg on 01.05.2023
07-03-2023
Midada
Published in Swissreg on 07.03.2023

3 endataziuns pli veglias

29-06-2022
Midada
Published in Swissreg on 29.06.2022
29-12-2021
Represchentant inscrit
Representative
OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern
Published in Swissreg on 29.12.2021
22-09-2021
Concedì
Published in Swissreg on 22.09.2021

Partidas

Possessur

Amgen Inc.

Amgen, Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

UCB Pharma S.A.

UCB Pharma, S.A.

Allée de la Recherche 60, 1070 Bruxelles, BE

Represchentant

OFFICE ERNEST FREYLINGER S.A.

c/o Schluep IP Law AG Falkenplatz 7, 3012 Bern

Inventur

Hoffmann, Kelly Sue

Newbury Park California 91320, US

Latham, John

Seattle Washington 98119, US

Robinson, Martyn Kim

Woodburn Green Buckinghamshire HP10 0JH, GB

Paszty, Christopher

Ventura California 93003, US

Winkler, David

Arlington Massachusetts 02476-7326, US

Winters, Aaron George

Ventura California 93001, US

Lawson, Alastair

Slough Berkshire SL1 3WE, GB

Henry, Alistair James

Uxbridge Middlesex UB 8 2LX, GB

Lu, Hsieng Sen

Westlake Village California 91362, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.